Deregulation of sphingolipid metabolism in Alzheimer's disease

Xingxuan He(Icahn School of Medicine at Mount Sinai), Edward H. Schuchman(Icahn School of Medicine at Mount Sinai), Bin Li(University of Hong Kong), Cheng‐Xin Gong(New York State Office for People With Developmental Disabilities), Yu Huang
Neurobiology of Aging
June 11, 2008
10.1016/j.neurobiolaging.2008.05.010
Cited by 529

Related Papers

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
|Nature Medicine|2008|833
Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis
|Cell|1996|797
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine -1-phosphate therapy
|Nature Medicine|2000|596
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|586
Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
|Molecular Therapy|2008|566